PUBLIC COMPANY
saveAlar Pharmaceuticals Inc
updated 4mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
🐶 Hiring Signal
News
- Indivior ends PAM drug collab with Addex ahead of Supernus mergerAhead of its upcoming merger with Supernus, Indivior Pharmaceuticals has ended its long-running collaboration with Addex Therapeutics to develop positive allosteric modulators (PAMs).fiercebiotech · 7d ago
- FDA issues untitled letter to Alar for false advertising of investigational drugThe US Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) has issued an untitled letter to Alar Pharmaceuticals, accusing the company of making misleading claims regard…raps · 1mo ago
comments(0)
5-min edit window · permanent after that